Aurobindo Pharma consolidated Q4 net profit up 79% - Qoneqt
seach-icon
  • user-img

    Ansari Uzair in India

    26 May 08:00 AM


    thumbnail

    Aurobindo Pharma consolidated Q4 net profit up 79%

    Aurobindo Pharmas strong financial performance in Q4FY24 and FY24, driven by revenue growth and net profit increase, was supported by market expansions, compliance enhancements, and regulatory adherence. The companys commitment to growth and operational stability remains firm.